In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Propanc Biopharma Inc (NASDAQ: PPCB) closed the day trading at $1.98 down -21.12% from the previous closing price of $2.51. In other words, the price has decreased by -$21.12 from its previous closing price. On the day, 0.53 million shares were traded. PPCB stock price reached its highest trading level at $2.55 during the session, while it also had its lowest trading level at $1.925.
Ratios:
For a better understanding of PPCB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.24 and its Current Ratio is at 2.24. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PPCB now has a Market Capitalization of 31655646 and an Enterprise Value of 24187738.
Stock Price History:
The Beta on a monthly basis for PPCB is 2.52, which has changed by 1979.0 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, PPCB has reached a high of $145.46, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is -63.93%, while the 200-Day Moving Average is calculated to be -82.99%.
Shares Statistics:
Over the past 3-months, PPCB traded about 2.11M shares per day on average, while over the past 10 days, PPCB traded about 655770 shares per day. A total of 11.61M shares are outstanding, with a floating share count of 11.37M. Insiders hold about 9.86% of the company’s shares, while institutions hold 0.00% stake in the company. Therefore, it implies a Short% of Shares Outstanding of 812 and a Short% of Float of 0.01.
